Michael Hess leads the firm’s Specialty Pharmacy & Pharmaceuticals Practice Group. His ability to balance legal issues with business issues has earned him a reputation as a go-to lawyer in the specialty pharmacy industry.
Mike’s ability to provide practical and impactful advice to specialty pharmacies is rooted in his first-hand experience as former Chief Counsel & VP of Strategic Development of Accredo Health Group, former Assistant General Counsel of Medco Health Solutions and as a private practice attorney to the industry. He now supports 40 percent of the largest independent specialty pharmacy companies located from Los Angeles to Orlando, serving as the outside general counsel. In addition, he has participated in many of the specialty pharmacy transactions coming to market during the past three years. Mike’s strategic business advice and transactional and regulatory guidance helps manufacturers and pharmacies get high-cost, complex specialty drugs from the manufacturer’s warehouse to the patient’s door, safely, legally, effectively and efficiently.
American Health Law Association (AHLA) — RAP Practice Group, Vice Chair (2004-2007)
Institute for Health Law & Policy (iHeLP), University of Memphis Cecil C. Humphreys School of Law — Advisory Board
Memphis Leadership Academy — Board of Trustees
National Infusion Center Association — Advisory Board
Make-a-Wish of the Mid-South — Board of Directors
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
Represented Community Pharmacy Partners in its investment by Altaris Capital Partners, LLC.
Served as lead healthcare regulatory counsel to Amazon (Nasdaq: AMZN) in its acquisition of PillPack
Provided healthcare regulatory and antitrust counsel to Avella Specialty Pharmacy in its sale to OptumRx
Represented Fred’s, Inc. in its sale of EntrustRx to CVS Health Corporation.
Represented a leading provider of 340B Drug Pricing Program services in its acquisition by a prescription benefit management subsidiary of a leading pharmacy healthcare provider
Represented Frazier Healthcare Partners in its acquisition of a specialty pharmacy platform
Assisted a biopharmaceutical manufacturer with a limited distribution network oncology drug launch
Chambers USA — Healthcare (2016-2020)
BTI Client Service All-Stars (2016, 2019)
Martindale-Hubbell — AV Preeminent® Peer Review Rated
The Best Lawyers in America© — Health Care Law (2014-2021)
Best Lawyers® — Memphis Health Care Law “Lawyer of the Year” (2018)
Client Choice Award — Healthcare & Life Sciences (2019)
Mid-South Super Lawyers (2009, 2018-2019)